Checkpoint Inhibitor irAE (Pneumonitis) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Checkpoint Inhibitor irAE (Pneumonitis)
Checkpoint inhibitor irAE pneumonitis is an inflammation of the lungs that can occur as a side effect of certain cancer immunotherapies. While these treatments are vital, managing their adverse effects can involve expensive medications. TheDrugClub helps members afford these crucial prescriptions, ensuring access to necessary care without the added financial strain.
Checkpoint inhibitors represent a significant advancement in cancer treatment, harnessing the body's own immune system to fight cancer cells. However, by activating the immune system, these therapies can sometimes lead to immune-related adverse events (irAEs), where the immune system mistakenly attacks healthy tissues. When
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.